2025. Generalized Pustular Psoriasis (GPP) Control is Limited on Traditional Small-molecule Therapy as Measured by the GPP Physician Global Assessment (GPPGA) and Dermatology Life Quality Index (DLQI): Baseline Data from the EFFISAYIL® 2 Trial. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s540. DOI:https://doi.org/10.25251/skin.10.supp.540.